Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd, as well as development collaboration with Eli Lilly and Company for developing ...

Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

Eli Lilly & Co. will set up a S$42 million ($31 million) digital health innovation hub in Singapore, expanding its research ...

Eli Lilly (LLY) and Company announced detailed results from the Phase 3 SURMOUNT-1 three-year study, the longest completed study to date of ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 23.80% higher than today’s price of $832.00.

Eli Lilly dominates the weight loss industry thanks to its dual agonists Mounjaro and Zepbound. Viking Therapeutics is a ...

Strategic partnerships with biotech firms enhance Eli Lilly and Company (NYSE:LLY)’s research capabilities and expedite the development of innovative therapies, keeping it at the forefront of ...

Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical firm that focuses on discovering, developing, and marketing medications. It offers a range of diabetes and obesity treatments ...